Genipin induced apoptosis associated with activation of the c-Jun NH2-terminal kinase and p53 protein in HeLa cells

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 8, 2010, Pages 1343-1348

  Cao, Houli ^a   Feng, Qian ^a   Xu, Wei ^a   Li, Xiaorong ^a   Kang, Zhuang ^a   Ren, Yanqin ^a   Du, Linfang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; c Jun NH2 terminal kinase; G1 phase; Genipin; HeLa cell; P53

Indexed keywords

GENIPIN; PROTEIN BAX; PROTEIN C JUN; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GROWTH INHIBITION; HELA CELL; HUMAN; HUMAN CELL; IC 50; PHARMACOLOGICAL BLOCKING; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLOW CYTOMETRY; HELA CELLS; HUMANS; IRIDOID GLYCOSIDES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEDICINE, CHINESE TRADITIONAL; MICROSCOPY, PHASE-CONTRAST; PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956122881     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1343     Document Type: Article

References (45)

1. Peng C. H., Tseng T. H., Liu J. Y., Hsieh Y. H., Huang C. N., Hsu S. P., Wang C. J., Chem. Biol. Interact., 147, 287-296 (2004).
2. Akao T., Kobayashi K., Aburada M., Biol. Pharm. Bull., 17, 1573-1576 (1994).
3. Yim J. S., Kim Y. S., Moon S. K., Cho K. H., Bae H. S., Kim J. J., Park E. K., Kim D. H., Biol. Pharm. Bull., 27, 1580-1583 (2004).
4. Koo H. J., Song Y. S., Kim H. J., Lee Y. H., Hong S. M., Kim S. J., Kim B. C., Jin C., Lim C. J., Park E. H., Eur. J. Pharmacol., 495, 201-208 (2004).
5. Yamazaki M., Chiba K., Mohri T., Hatanaka H., J. Neurochem., 79, 45-54 (2001).
6. Yamazaki M., Chiba K., Mohri T., Hatanaka H., Eur. J. Pharmacol., 488, 35-43 (2004).
7. Wang G. F., Wu S. Y., Rao J. J., Lu L., Xu W., Pang J. X., Liu Z. Q., Wu S. G., Zhang J. J., Acta Pharmacol. Sin., 30, 589-596 (2009).
8. Kim B. C., Kim H. G., Lee S. A., Lim S., Park E. H., Kim S. J., Lim C. J., Biochem. Pharm., 70, 1398-1407 (2005).
9. Hong H. Y., Kim B. C., Biochem. Biophys. Res. Commun., 362, 307-312 (2007).
10. Kerr J. F. R., Winterford C. M., Harmon B. V., Cancer, 73, 2013-2026 (1994).
11. Jimenez Del Rio M., Velez-Pardo C., Biochem. Pharmacol., 63, 677-688 (2002).
12. Velez-Pardo C., Ospina G. G., Jimenez del Rio M., Neuro. Toxicol., 23, 351-365 (2002).
13. Adler V., Franklin C. C., Kraft A. S., Proc. Natl. Acad. Sci. U.S.A., 89, 5341-5345 (1992).
14. Davis R. J., Cell, 103, 239-252 (2000).
15. Hibi M., Lin A., Smeal T., Minden A., Karin M., Genes Dev., 7, 2135-2148 (1993).
16. Culmsee C., Mattson M. P., Biochem. Biophys. Res. Commun., 331, 761-777 (2005).
17. Inamura N., Enokido Y., Hatanaka H., Brain Res., 904, 270-278 (2001).
18. Michalovitz D., Halevi O., Oren M., Cell, 62, 671-680 (1990).
19. Er E., Oliver L., Cartron P. F., Juin P., Manon S., Vallette F. M., Biochim. Biophys. Acta, 1757, 1301-1311 (2006).
20. Li Z. Y., Liu Y., Zhao X., Pan X. L., Yin R., Huang C. H., Chen L. J., Wei Y. Q., Eur. J. Obstet. Gynecol. Reprod. Biol., 140, 95-102 (2008).
21. Kirazov L. P., Venkov L. G., Kirazov E. P., Anal. Biochem., 208, 44-48 (1993).
22. Mosmann T., J. Immunol. Methods, 65, 55-63 (1983).
23. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F., Cytometry, 13, 795-808 (1992).
24. Luo Y., Hattori A., Munoz J., Qin Z. H., Roth G. S., Mol. Pharmacol., 56, 254-264 (1999).
25. Guo Y. L., Baysal K., Kang B., Yang L. J., Williamson J. R., J. Biol. Chem., 273, 4027-4034 (1998).
26. Oh H. L., Lim H., Cho Y. H., Koh H. C., Kim H., Lim Y., Lee C. H., Bioorg. Med. Chem. Lett., 19, 959-961 (2009).
27. Chen N. H., Zhong J. J., Process Biochem., 44, 928-933 (2009).
28. Shen Y., White E., Adv. Cancer Res., 82, 55-84 (2001).
29. Sung H. W., Huang R. N., Huang L. L. H., Tsai C. C., J. Biomater. Sci. Polym. Ed., 10, 63-78 (1999).
30. Cho Y. J., Kim S. Y., Kim J., Choe E. K., Kim S. I., Shin H. J., Biotechnol. Bioprocess Eng., 11, 230-234 (2006).
31. Chang Y. C., Chou F. P., Huang H. P., Hsu J. D., Wang C. J., Toxicol. Appl. Pharmacol., 198, 11-20 (2004).
32. Vidal A., Koff A., Gene, 247, 1-15 (2000).
33. Bartek J., Lukas J., FEBS Lett., 490, 117-122 (2001).
34. Yang X. L., Khosravi-Far R., Chang H. Y., Baltimore D., Cell, 89, 1067-1076 (1997).
35. Kim Y. H., Park E. J., Han S. T., Park J. W., Kwon T. K., Life Sci., 77, 2783-2793 (2005).
36. Fuchs S. Y., Adler V., Pincus M. R., Ronai Z., Proc. Natl. Acad. Sci. U.S.A., 95, 10541-10546 (1998).
37. Fuchs S. Y., Adler V., Buschmann T., Yin Z., Wu X., Jones S. N., Ronai Z., Genes Dev., 12, 2658-2663 (1998).
38. Kubbutat M. H. G., Jones S. N., Vousden K. H., Nature (London), 387, 299-303 (1997).
39. Nango R., Terada C., Tsukamoto I., Eur. J. Pharmacol., 471, 1-8 (2003).
40. Chang Y. C., Tseng T. H., Lee M. J., Hsu J. D., Wang C. J., Chem. Biol. Interact., 141, 243-257 (2002).
41. Peng C. H., Tseng T. H., Huang C. N., Hsu S. P., Wang C. J., Toxicol. Appl. Pharmacol., 202, 172-179 (2005).
42. Mousavi S. H., Tavakkol-Afshari J., Brook A., Jafari-Anarkooli I., Food Chem. Toxicol., 47, 1909-1913 (2009).
43. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., Wang X., Cell, 91, 479-489 (1997).
44. Shin S. Y., Yong Y., Kim C. G., Lee Y. H., Lim Y., Cancer Lett., 287, 231-239 (2010).
45. Blum D., Wu Y., Nissou M. F., Arnaud S., Alim L. B., Verna J. M., Brain Res., 751, 139-142 (1997).